Eagle Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Eagle Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-561,018	Closed	-$42.4M	–	689
2020 Q3	$42.4M	Sell	561,018 -221,955	-28%	-$14.8M	0.22%	160
2020 Q2	$49.1M	Sell	782,973 -164,117	-17%	-$9.03M	0.28%	137
2020 Q1	$39.8M	Buy	947,090 +7,176	+0.8%	+$329K	0.25%	151
2019 Q4	$42.7M	Sell	939,914 -6,875	-0.7%	-$325K	0.21%	185
2019 Q3	$43.3M	Buy	946,789 +9,537	+1%	+$536K	0.22%	167
2019 Q2	$55M	Sell	937,252 -2,255	-0.2%	-$117K	0.28%	137
2019 Q1	$42.1M	Buy	+939,507	New	+$43.1M	0.22%	172

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Eagle Asset Management's ARNA Position: Q4 2020 in Review

Eagle Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 561,018 shares — an estimated $42.4M sold.

Eagle Asset Management first reported a position in ARNA in Q1 2019 and held it in 7 quarters. The position peaked at $55M in Q2 2019. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

Eagle Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
Eagle Asset Management sold 561,018 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $42.4M.
Eagle Asset Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 7 quarters.
Eagle Asset Management's Arena Pharmaceuticals Inc position peaked at $55M in Q2 2019.
254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Eagle Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.